The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines
- PMID: 3283655
The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines
Abstract
In this study, we have employed both indirect immunofluorescence and ELISA assays to compare the relative levels of c-myc protein in cell lines derived from normal human colon and colon adenocarcinomas. We show that the levels of protein found in the majority of carcinoma cell lines are consistent with the levels of mRNA expressed, and that both are significantly elevated with respect to the levels found in normal cells. Growing populations of fibroblastic and epithelial cell lines derived from normal colonic mucosa exhibit small numbers of steady-state transcripts and immunofluorescence signals which are weak and confined to the nucleus. The adenocarcinoma cell lines, however, express 5- to 10-fold elevated levels of c-myc mRNA and exhibit correspondingly intense immunofluorescence signals which appear to reside principally in the nucleus. Quantitation of c-myc protein levels in these tumor cell lines by ELISA assay indicates that they are 8- to 37-fold higher than the levels of protein in normal cells. Elevated expression of the c-myc gene at both the mRNA and protein levels occurs constitutively in the colorectal carcinoma cell lines during their growth in culture, in contrast to the transiently elevated levels of expression observed in normal cells which have been subjected to a mitogenic stimulus. The constitutively elevated expression of the c-myc protein in colorectal carcinoma cell lines is not typically accompanied by gross rearrangement or amplification of the gene.
Similar articles
-
Oncogene expression in adenocarcinomas of the colon and in colon tumor-derived cell lines.Anticancer Res. 1988 Jan-Feb;8(1):1-7. Anticancer Res. 1988. PMID: 3282475
-
Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors.Cancer Res. 1992 Nov 1;52(21):5853-64. Cancer Res. 1992. PMID: 1394214
-
Elevated c-myc messenger RNA in multiple myeloma cell lines.Dis Markers. 1990 May-Jun;8(3):117-24. Dis Markers. 1990. PMID: 1980237
-
The role of the oncogene c-myc in sporadic large bowel cancer and familial polyposis coli.Semin Surg Oncol. 1987;3(3):152-8. doi: 10.1002/ssu.2980030305. Semin Surg Oncol. 1987. PMID: 2821605 Review.
-
Synthesis and secretion of nascent lipoprotein particles.Prog Lipid Res. 1991;30(2-3):219-30. doi: 10.1016/0163-7827(91)90018-z. Prog Lipid Res. 1991. PMID: 1668560 Review. No abstract available.
Cited by
-
Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.Mol Cell Biol. 1994 Dec;14(12):7805-15. doi: 10.1128/mcb.14.12.7805-7815.1994. Mol Cell Biol. 1994. PMID: 7969121 Free PMC article.
-
Suppression of deregulated c-MYC expression in human colon carcinoma cells by chromosome 5 transfer.Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1482-6. doi: 10.1073/pnas.89.4.1482. Proc Natl Acad Sci U S A. 1992. PMID: 1741403 Free PMC article.
-
Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.Gut. 2002 May;50(5):658-64. doi: 10.1136/gut.50.5.658. Gut. 2002. PMID: 11950812 Free PMC article.
-
Differential pp60c-src activity in well and poorly differentiated human colon carcinomas and cell lines.J Clin Invest. 1992 Sep;90(3):815-21. doi: 10.1172/JCI115956. J Clin Invest. 1992. PMID: 1381724 Free PMC article.
-
gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.Genes Dev. 2000 Jun 1;14(11):1319-31. Genes Dev. 2000. PMID: 10837025 Free PMC article.